Jerod Funke

Human Resources Officer at INFUSYSTEM HOLDINGS, INC.

Net worth: 268 962 $ as of 31/05/2026

51 year

22 connections

Health Technology

Commercial Services

Consumer Services

Profile

Jerod Funke is Chief Human Resources Officer & Executive VP at InfuSystem Holdings, Inc. since 2023.
Formerly, Mr. Funke was Vice President-Global Talent Acquisition at Insulet Corp.
from 2021 to 2023 and Vice President-Global Talent Acquisition at Vertex Pharmaceuticals, Inc. from 2017 to 2021.
Education includes undergraduate and graduate degrees from Boston College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INFUSYSTEM HOLDINGS, INC. 0.15%	17/05/2026	29,654 ( 0.15% )	268 962 $	31/05/2026

Jerod Funke active positions

Companies	Position	Start
INFUSYSTEM HOLDINGS, INC.	Human Resources Officer	01/10/2023

All active positions of Jerod Funke

Former positions of Jerod Funke

Companies	Position	End
INSULET CORPORATION	Corporate Officer/Principal	01/10/2023
VERTEX PHARMACEUTICALS INCORPORATED	Corporate Officer/Principal	01/02/2021

See the detail of Jerod Funke's experience

Training of Jerod Funke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jerod Funke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Vertex Pharmaceuticals, Inc. Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis	Health Technology
InfuSystem Holdings, Inc. InfuSystem Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Manufactures external ambulatory infusion pumps	Commercial Services
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Insulet Corp. Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems	Health Technology